Once youre a patient, you message your provider directly
HealthRX did not receive compensation from any platform listed
Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
[DOI] [PubMed] [Google Scholar] 102.Sepidarkish M, Farsi F, Akbari-Fakhrabadi M, Namazi N, Almasi-Hashiani A, Maleki Hagiagha A, Heshmati J
As of June 2026, MT-2 is not approved by the FDA, EMA, MHRA, or TGA for any use
Our 5-week study demonstrated significant increases in body weight from baseline in male and female WT mice with cold stress, despite significant decreases in adiposity, consistent with lower plasma leptin levels
.webp)
.png)
